SIM
MBIO icon

Spark Investment Management’s Mustang Bio MBIO Stock Holding History

Spark Investment Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-42
Closed -$217K – 708
2018
Q2 		$217K Buy
+42
New +$265K 0.01% 545

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Spark Investment Management's MBIO Position: Q3 2018 in Review

Spark Investment Management sold out of Mustang Bio (MBIO) in Q3 2018, closing a stake of 42 shares — an estimated $217K sold.

Spark Investment Management first reported a position in MBIO in Q2 2018 and held it in 1 quarter. The position peaked at $217K in Q2 2018. 36 funds tracked by Wall St. Rank hold MBIO as of Q3 2018.

  • Spark Investment Management reported no remaining Mustang Bio position as of Q3 2018 after selling out during the quarter.
  • Spark Investment Management sold 42 Mustang Bio shares in Q3 2018, an estimated $217K.
  • Spark Investment Management first reported a position in Mustang Bio in Q2 2018 and held it in 1 quarter.
  • Spark Investment Management's Mustang Bio position peaked at $217K in Q2 2018.
  • 36 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2018.

Based on Spark Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.